Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Total Long Term Liabilities 2010-2025 | HYPMY

Hypermarcas total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
  
Hypermarcas Annual Total Long Term Liabilities
(Millions of US $)
2024 $1,579
2023 $1,672
2022 $1,525
2021 $1,336
2020 $1,044
2019 $412
2018 $238
2017 $214
2016 $268
2015 $1,356
2014 $1,462
2013 $1,634
2012 $2,126
2011 $3,053
2010 $1,816
2009 $789
Hypermarcas Quarterly Total Long Term Liabilities
(Millions of US $)
2025-03-31 $1,353
2024-12-31 $1,579
2024-09-30 $1,588
2024-06-30 $1,684
2024-03-31 $1,768
2023-12-31 $1,672
2023-09-30 $1,758
2023-06-30 $1,750
2023-03-31 $1,574
2022-12-31 $1,525
2022-09-30 $1,509
2022-06-30 $1,440
2022-03-31 $1,331
2021-12-31 $1,336
2021-09-30 $1,326
2021-06-30 $1,140
2021-03-31 $1,157
2020-12-31 $1,044
2020-09-30 $1,026
2020-06-30 $843
2020-03-31 $392
2019-12-31 $412
2019-09-30 $203
2019-06-30 $215
2019-03-31 $248
2018-12-31 $238
2018-09-30 $208
2018-06-30 $204
2018-03-31 $221
2017-12-31 $214
2017-09-30 $256
2017-06-30 $241
2017-03-31 $248
2016-12-31 $268
2016-09-30 $551
2016-06-30 $587
2016-03-31 $471
2015-12-31 $1,356
2015-09-30 $1,202
2015-06-30 $1,261
2015-03-31 $1,201
2014-12-31 $1,462
2014-09-30 $1,741
2014-06-30 $1,851
2014-03-31 $1,620
2013-12-31 $1,634
2013-09-30 $1,790
2013-06-30 $1,756
2013-03-31 $1,894
2012-12-31 $2,126
2012-09-30 $2,292
2012-06-30 $2,503
2012-03-31 $2,720
2011-12-31 $3,053
2011-09-30 $3,273
2011-06-30 $3,127
2011-03-31 $2,590
2010-12-31 $1,816
2010-09-30 $1,455
2010-06-30 $1,075
2010-03-31 $946
2009-12-31 $789
2009-09-30 $491
2009-06-30 $343
2009-03-31 $393
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.724B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.384B 33.53
Zoetis (ZTS) United States $75.427B 28.14
Daiichi Sankyo, - (DSNKY) Japan $51.906B 26.41
Takeda Pharmaceutical (TAK) Japan $47.983B 9.54
Sandoz Group AG (SDZNY) Switzerland $22.594B 0.00
Merck (MKKGY) Germany $17.021B 12.47
United Therapeutics (UTHR) United States $14.681B 12.99
Shionogi (SGIOY) Japan $14.275B 14.30
Summit Therapeutics (SMMT) United States $13.164B 0.00
Neurocrine Biosciences (NBIX) United States $12.327B 42.22
IPSEN (IPSEY) France $10.095B 0.00
Orion OYJ (ORINY) Finland $9.462B 25.59
Corcept Therapeutics (CORT) United States $7.601B 61.79
Stevanato Group S.p.A (STVN) Italy $6.638B 40.59
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.054B 0.00
Grifols, S.A (GRFS) Spain $5.707B 0.00
Ionis Pharmaceuticals (IONS) United States $5.429B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.813B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.037B 10.64
Crinetics Pharmaceuticals (CRNX) United States $2.985B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.326B 12.58
BioCryst Pharmaceuticals (BCRX) United States $2.245B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.125B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.791B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.776B 0.00
Indivior (INDV) United States $1.718B 7.29
Dyne Therapeutics (DYN) United States $1.444B 0.00
ARS Pharmaceuticals (SPRY) United States $1.420B 0.00
Evotec AG (EVO) Germany $1.413B 0.00
Guardian Pharmacy Services (GRDN) United States $1.347B 0.00
Ocular Therapeutix (OCUL) United States $1.292B 0.00
Harrow (HROW) United States $1.100B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.075B 21.51
Collegium Pharmaceutical (COLL) United States $0.942B 5.08
Enliven Therapeutics (ELVN) United States $0.939B 0.00
Ardelyx (ARDX) United States $0.921B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.918B 0.00
Akebia Therapeutics (AKBA) United States $0.854B 0.00
Xeris Biopharma Holdings (XERS) United States $0.790B 0.00
Cronos Group (CRON) Canada $0.740B 0.00
AleAnna (ANNA) United States $0.647B 0.00
KalVista Pharmaceuticals (KALV) United States $0.642B 0.00
Xencor (XNCR) United States $0.611B 0.00
Elite Pharmaceuticals (ELTP) United States $0.571B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.558B 0.00
Regulus Therapeutics (RGLS) United States $0.550B 0.00
Relay Therapeutics (RLAY) United States $0.545B 0.00
USANA Health Sciences (USNA) United States $0.544B 11.83
Bioventus (BVS) United States $0.529B 13.42
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.441B 0.00
Tourmaline Bio (TRML) United States $0.439B 0.00
Siga Technologies (SIGA) United States $0.434B 9.07
Altimmune (ALT) United States $0.430B 0.00
Verve Therapeutics (VERV) United States $0.427B 0.00
Savara (SVRA) United States $0.415B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.360B 9.73
Organogenesis (ORGO) United States $0.337B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
Aquestive Therapeutics (AQST) United States $0.279B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.279B 0.00
Nature's Sunshine Products (NATR) United States $0.258B 23.80
MediWound (MDWD) Israel $0.240B 0.00
ProKidney (PROK) United States $0.218B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
Esperion Therapeutics (ESPR) United States $0.182B 0.00
Journey Medical (DERM) United States $0.182B 0.00
4D Molecular Therapeutics (FDMT) United States $0.174B 0.00
OmniAb (OABI) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Inhibikase Therapeutics (IKT) United States $0.152B 0.00
Nektar Therapeutics (NKTR) United States $0.148B 0.00
Larimar Therapeutics (LRMR) United States $0.141B 0.00
Liminatus Pharma (LIMN) $0.140B 0.00
Achieve Life Sciences (ACHV) Canada $0.135B 0.00
Wellgistics Health (WGRX) United States $0.135B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Aldeyra Therapeutics (ALDX) United States $0.127B 0.00
Lyell Immunopharma (LYEL) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.102B 0.00
Korro Bio (KRRO) United States $0.101B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 63.44
Galectin Therapeutics (GALT) United States $0.082B 0.00
Unicycive Therapeutics (UNCY) United States $0.080B 0.00
Champions Oncology (CSBR) United States $0.079B 13.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.073B 0.00
Surrozen (SRZN) United States $0.070B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
Lyra Therapeutics (LYRA) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.90
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00